Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.65
Delayed Data
As of Feb 23
 +0.05 / +0.89%
Today’s Change
5.25
Today|||52-Week Range
6.64
-4.24%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close5.60
Today’s open5.67
Day’s range5.60 - 5.69
Volume13,948
Average volume (3 months)97,113
Market cap$318.7M
Dividend yield--
Data as of 02/23/2017

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+600.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+6.84%
P/E ratioNM
Price/Sales4.78
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.50-5.41%
CCXIChemoCentryx Inc-0.22-3.36%
OMEDOncoMed Pharmaceutic...+0.10+1.13%
SRNESorrento Therapeutic...-0.05-0.95%
Data as of 02/23/2017

Financials

Next reporting dateApril 11, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$67.4M
Annual profit (last year)-$1.1M
Net profit margin-0.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts


Search for Jobs